The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Recruiting · NCT06577805 · Observational (researchers observe without assigning treatment) · Lead sponsor: West China Hospital
View the official record on ClinicalTrials.gov →What this trial is about
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- living-donor kidney transplant recipients
- receiving standard triad immunosuppressive regimen
Exclusion criteria
- active infection
- multi-organ transplantation
- malignancy history in the donor and recipient
- human immunodeficiency virus infection
Where it is running
1 location listed.
- West China Hospital, Sichuan University - Chengdu, Sichuan, China